EUS-B-FNA for left adrenal gland analysis in lung cancer patients.

EUS-B-FNA for left adrenal gland analysis in lung cancer patients. - EUS-B-FNA for left adrenal gland analysis

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON42163

Enrollment

Registered

2014-12-11

Start date

2015-03-11

Completion date

Unknown

Last updated

2024-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

lung cancer

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: lung cancer suspected left adrenal gland on imaging

Exclusion criteria

Exclusion criteria: contraindication for EUS/EUS-B

Design outcomes

Primary

Measure	Time frame
The proportion of patients with a successful EUS-B-FNA procedure for LAG analysis.	—

Secondary

Measure	Time frame
Sensitivity EUS-B-FNA and EUS-FNA for LAG metastases.	—

Countries

Netherlands

Outcome results